Cargando…
Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417259/ https://www.ncbi.nlm.nih.gov/pubmed/32791053 http://dx.doi.org/10.1016/j.clinbiochem.2020.08.004 |
| _version_ | 1783569455803006976 |
|---|---|
| author | Seegmiller, Jesse C. Kokaisel, Emily L. Story, Steven J. Zaun, Christopher P. Peters, Jennifer M. Thomas, Stefani N. Karger, Amy B. |
| author_facet | Seegmiller, Jesse C. Kokaisel, Emily L. Story, Steven J. Zaun, Christopher P. Peters, Jennifer M. Thomas, Stefani N. Karger, Amy B. |
| author_sort | Seegmiller, Jesse C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7417259 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74172592020-08-11 Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay Seegmiller, Jesse C. Kokaisel, Emily L. Story, Steven J. Zaun, Christopher P. Peters, Jennifer M. Thomas, Stefani N. Karger, Amy B. Clin Biochem Letter to the Editor Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists. 2020-12 2020-08-11 /pmc/articles/PMC7417259/ /pubmed/32791053 http://dx.doi.org/10.1016/j.clinbiochem.2020.08.004 Text en © 2020 Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Seegmiller, Jesse C. Kokaisel, Emily L. Story, Steven J. Zaun, Christopher P. Peters, Jennifer M. Thomas, Stefani N. Karger, Amy B. Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay |
| title | Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay |
| title_full | Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay |
| title_fullStr | Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay |
| title_full_unstemmed | Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay |
| title_short | Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay |
| title_sort | method comparison of sars-cov-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417259/ https://www.ncbi.nlm.nih.gov/pubmed/32791053 http://dx.doi.org/10.1016/j.clinbiochem.2020.08.004 |
| work_keys_str_mv | AT seegmillerjessec methodcomparisonofsarscov2serologyassaysinvolvingthreecommerciallyavailableplatformsandanovelinhousedevelopedenzymelinkedimmunosorbentassay AT kokaiselemilyl methodcomparisonofsarscov2serologyassaysinvolvingthreecommerciallyavailableplatformsandanovelinhousedevelopedenzymelinkedimmunosorbentassay AT storystevenj methodcomparisonofsarscov2serologyassaysinvolvingthreecommerciallyavailableplatformsandanovelinhousedevelopedenzymelinkedimmunosorbentassay AT zaunchristopherp methodcomparisonofsarscov2serologyassaysinvolvingthreecommerciallyavailableplatformsandanovelinhousedevelopedenzymelinkedimmunosorbentassay AT petersjenniferm methodcomparisonofsarscov2serologyassaysinvolvingthreecommerciallyavailableplatformsandanovelinhousedevelopedenzymelinkedimmunosorbentassay AT thomasstefanin methodcomparisonofsarscov2serologyassaysinvolvingthreecommerciallyavailableplatformsandanovelinhousedevelopedenzymelinkedimmunosorbentassay AT kargeramyb methodcomparisonofsarscov2serologyassaysinvolvingthreecommerciallyavailableplatformsandanovelinhousedevelopedenzymelinkedimmunosorbentassay |